Beta-blockers in cirrhosis patients with refractory ascites

Hepatology

Volumn 59, Issue 5, 2014, Pages 2054-2055

  Robins, Anne ^a   Bowden, Anne ^a   Watson, William ^a   Smith, Fiona ^a   Gelson, William ^a   Griffiths, William ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC BETA-ANTAGONISTS; ASCITES; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; PROPRANOLOL;

EID: 84899493871     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26676     Document Type: Letter

References (8)

1. Serste T, Melot C, Francoz C, Durand F, Rautou PE, Valla D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 2010;52:1017-1022.
2. Serste T, Francoz C, Durand F, Rautou PE, Melot C, Valla D, et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. Hepatology 2011;55:794-799.
3. Wong F, Salerno F. Beta-blockers in cirrhosis: friend and foe? Hepatology 2010;52:811-813.
4. Krag A, Bendtsen F, Moller S. Does cardiac dysfuction explain deleterious effects of beta-blockers in cirrhosis and refractory ascites? Hepatology 2011;53:370-371.
5. Efe C, Purnak T, Ozaslan E. The deleterious effects of propranolol on patients with cirrhosis. Hepatology 2011;53:371.
6. Albillos A, Zamora J. Beta-blockers in patients with cirrhosis and refractory ascites. Hepatology 2011;53:1783.
7. Garcia-Pagan JC. Portal hypertension: non selective beta-blockers in patients with refractory ascites. Nat Rev Gastroenterol Hepatol 2011;8:10-11.
8. Galbois A, Das V, Thabut D, Maury E, Ait-Oufella H, Housset C, et al. Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections. Hepatology 2011;53:1412-1413.